Literature DB >> 9407388

Gene delivery to rat enteric neurons using herpes simplex virus-based vectors.

M K Howard1, R S Coffin, A R Maclean, S M Brown, D Bailey, P N Anderson, G Burnstock, D S Latchman.   

Abstract

Neurons of the enteric (gut) nervous system can be cultured in vitro and readily survive transplantation into the brain making close connections with host neurons. As such, they could potentially be used to deliver therapeutic gene products to the brain after transduction with appropriate genes in culture. Here the authors report the first example of gene delivery to such cultured neurons using herpes simplex virus based vectors. They show that viruses lacking the immediate early gene encoding ICP27 (which are unable to replicate lytically) can efficiently deliver a marker gene to enteric neurons without producing extensive cellular damage. In contrast, viruses lacking only the viral neurovirulence factor encoded by ICP34.5 are inefficient in gene delivery, and produce extensive cellular damage, although they cannot replicate lytically in enteric neurons. A virus lacking both ICP27 and ICP34.5, however, produces less cellular damage than one lacking only ICP27, and is as efficient in gene transfer, whereas inactivation of VMW65 reduces toxicity further. The identification of this virus as a safe and efficient gene delivery vector for enteric neurons paves the way for the eventual delivery of therapeutic genes and subsequent transplantation of engineered neurons into the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407388     DOI: 10.1007/bf02736851

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Growth of enteric neurones from isolated myenteric ganglia in dissociated cell culture.

Authors:  M J Saffrey; D J Bailey; G Burnstock
Journal:  Cell Tissue Res       Date:  1991-09       Impact factor: 5.249

2.  The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons.

Authors:  K A Lillycrop; C L Dent; S C Wheatley; M N Beech; N N Ninkina; J N Wood; D S Latchman
Journal:  Neuron       Date:  1991-09       Impact factor: 17.173

3.  Implantation of the myenteric plexus into the corpus striatum of adult rats: survival of the neurons and glia and interactions with host brain.

Authors:  E M Tew; P N Anderson; G Burnstock
Journal:  Restor Neurol Neurosci       Date:  1992-01-01       Impact factor: 2.406

4.  A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons.

Authors:  A T Dobson; T P Margolis; F Sedarati; J G Stevens; L T Feldman
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

5.  Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.

Authors:  C I Ace; T A McKee; J M Ryan; J M Cameron; C M Preston
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Herpesvirus infections of the human central nervous system.

Authors:  L C Olson; E L Buescher; M S Artenstein; P D Parkman
Journal:  N Engl J Med       Date:  1967-12-14       Impact factor: 91.245

7.  The enteric nervous system in tissue culture. III. Studies on neuronal survival and the retention of biochemical and morphological differentiation.

Authors:  K R Jessen; M J Saffrey; P Bałuk; M Hanani; G Burnstock
Journal:  Brain Res       Date:  1983-02-28       Impact factor: 3.252

8.  Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors.

Authors:  R S Coffin; M K Howard; D V Cumming; C M Dollery; J McEwan; D M Yellon; M S Marber; A R MacLean; S M Brown; D S Latchman
Journal:  Gene Ther       Date:  1996-07       Impact factor: 5.250

9.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

Authors:  W R Sacks; C C Greene; D P Aschman; P A Schaffer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression.

Authors:  M B Rosenberg; T Friedmann; R C Robertson; M Tuszynski; J A Wolff; X O Breakefield; F H Gage
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  2 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Adeno-Associated Viral Vector Delivery to the Enteric Nervous System: A Review.

Authors:  Sara E Gombash
Journal:  Postdoc J       Date:  2015-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.